Phibro Animal Health Corporation Announces Licensing Agreement With Merial for Phibro's Vaccine Delivery Technology
The patented technology utilizes an innovative effervescent tablet that contains a freeze-dried sterile vaccine virus, packaged in sealed aluminum blister packages. The technology replaces the glass vials that are in common use today, and offers major advantages in a number of areas including storage requirements, customer handling and disposal.
Under the arrangement, use of the technology will be limited to
Phibro Animal Health Corporation Richard JohnsonChief Financial Officer +1-201-329-7300 firstname.lastname@example.org
News Provided by Acquire Media